Date Hour Room Track
29th November,2017 9:00 - 10:30 am Salon Madrid 4 Track 2
  • To what extent should the scientists manage the future of the spin off?
  • What is their role within a new professional management team?
  • Can we impose on a scientist the role of being a CEO? What are the pro’s and con’s of the Professor becoming the CEO of his own spin-off?
  • What needs to be considered when forming a company and what does that mean for the founding scientist?
Eric Halioua - PDC*line Pharma
Davidson Ateh - BioMoti
Barbara Domayne-Hayman - Puridify UK
Tony Hickson - Imperial Innovations
Egil Hulgaard - Technical University of Denmark
Sascha Berger - TVM Capital

Continue your tour